2019 Annual Meeting | C41 - Neuro-oncology in 2019: Navigating Current Trends

Date Sunday 05/05/19

Time 07:00 AM - 09:00 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Maciej M. Mrugala, MD, PhD, MPH, F�鶹��ýӳ��

Topic(s) Neuro-oncology

Learning Objectives Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:05 AM - 07:05 AM EDT	Speaker	Introduction Maciej M. Mrugala, MD, PhD, MPH, F�鶹��ýӳ��
07:05 AM - 07:45 AM EDT	Speaker	Deciphering Molecular Testing in Neuro-oncology Seema Nagpal, MD, F�鶹��ýӳ��
07:45 AM - 08:20 AM EDT	Speaker	Medical Therapies in Neuro-oncology: What is New? Maciej M. Mrugala, MD, PhD, MPH, F�鶹��ýӳ��
08:20 AM - 09:00 AM EDT	Speaker	Advances in Neurosurgical Treatment of Brain Tumors Daniel P. Cahill, MD, PhD

Faculty Disclosures
Maciej M. Mrugala, MD, PhD, MPH, F�鶹��ýӳ��	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to �鶹��ýӳ�� interests or activities.
Seema Nagpal, MD, F�鶹��ýӳ��	Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Daiichi-Sankyo. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Enclear. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Plus Therapuetics/Biocept. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure.
Daniel P. Cahill, MD, PhD	Daniel P. Cahill, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Advise Connect Inspire. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for German Accelerator. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Incephalo. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.